If a variant has more than one submission, it may be counted in more than one significance column. If this is the
case, the total number of variants will be less than the sum of the other cells.
| pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
not provided |
total |
|
1485
|
418
|
2484
|
1099
|
224
|
12
|
5560
|
Gene and significance breakdown #
Total genes and gene combinations: 28
| Gene or gene combination |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
not provided |
total |
|
MSH6
|
263
|
106
|
967
|
449
|
52
|
5
|
1785
|
|
MSH2
|
526
|
114
|
644
|
249
|
58
|
4
|
1558
|
|
MLH1
|
554
|
128
|
408
|
189
|
60
|
0 |
1298
|
|
PMS2
|
122
|
67
|
435
|
201
|
41
|
3
|
841
|
|
EPCAM
|
4
|
0 |
14
|
4
|
0 |
0 |
22
|
|
LOC129933707, MSH6
|
1
|
3
|
8
|
5
|
1
|
0 |
18
|
|
LOC129933695, MSH2
|
5
|
0 |
0 |
0 |
0 |
0 |
5
|
|
FBXO11, MSH6
|
1
|
0 |
0 |
1
|
2
|
0 |
4
|
|
AIMP2, PMS2
|
0 |
0 |
0 |
0 |
3
|
0 |
3
|
|
EPCAM, MIR559
|
1
|
0 |
2
|
0 |
0 |
0 |
3
|
|
LOC129933706, MSH6
|
0 |
0 |
0 |
0 |
3
|
0 |
3
|
|
LOC129997916, PMS2
|
2
|
0 |
1
|
0 |
0 |
0 |
3
|
|
LOC129933705, LOC129933706, LOC129933707, LOC129933708, MSH6
|
2
|
0 |
0 |
0 |
0 |
0 |
2
|
|
LOC129933706, LOC129933707, LOC129933708, MSH6
|
1
|
0 |
1
|
0 |
0 |
0 |
2
|
|
RPS20
|
0 |
0 |
0 |
0 |
2
|
0 |
2
|
|
CDH1
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
|
EPCAM, STPG4
|
0 |
0 |
0 |
1
|
0 |
0 |
1
|
|
EPM2AIP1, LOC115995508, LOC129936464, LOC129936465, LOC129936466, LOC129936467, LOC129936468, LOC129936469, LOC129936470, LOC129936471, MLH1, TRANK1
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
|
EPM2AIP1, MLH1
|
0 |
0 |
0 |
0 |
1
|
0 |
1
|
|
FBXO11, LOC129933706, LOC129933707, LOC129933708, MSH6
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
|
LOC129933706, LOC129933707, MSH6
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
|
LOC129933707, LOC129933708, MSH6
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
|
LOC129936471, MLH1
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
|
LRRFIP2, MLH1
|
0 |
0 |
0 |
0 |
1
|
0 |
1
|
|
MLH3
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
|
NF1
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
|
PMS1
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
|
TGFBR2
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
Submitter and significance breakdown #
| Submitter |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
not provided |
total |
|
All of Us Research Program, National Institutes of Health
|
187
|
47
|
2157
|
933
|
33
|
0 |
3357
|
|
International Society for Gastrointestinal Hereditary Tumours (InSiGHT)
|
1160
|
173
|
23
|
89
|
173
|
0 |
1618
|
|
Department of Pathology and Laboratory Medicine, Sinai Health System
|
83
|
9
|
177
|
89
|
10
|
0 |
367
|
|
University of Washington Department of Laboratory Medicine, University of Washington
|
53
|
27
|
123
|
41
|
6
|
0 |
250
|
|
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
|
112
|
82
|
1
|
0 |
0 |
1
|
196
|
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
|
71
|
61
|
5
|
2
|
47
|
0 |
186
|
|
Labcorp Genetics (formerly Invitae), Labcorp
|
88
|
8
|
42
|
6
|
0 |
0 |
144
|
|
Mendelics
|
13
|
1
|
84
|
0 |
0 |
0 |
98
|
|
Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet
|
22
|
22
|
3
|
4
|
0 |
0 |
51
|
|
GeneKor MSA
|
20
|
7
|
0 |
0 |
24
|
0 |
51
|
|
Clinical and Functional Genomics Group, A.C.Camargo Cancer Center
|
27
|
1
|
5
|
0 |
0 |
0 |
33
|
|
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
|
0 |
0 |
16
|
2
|
13
|
0 |
31
|
|
St. Jude Molecular Pathology, St. Jude Children's Research Hospital
|
1
|
0 |
26
|
3
|
1
|
0 |
31
|
|
CSER _CC_NCGL, University of Washington
|
1
|
3
|
8
|
3
|
1
|
0 |
16
|
|
Human Genome Sequencing Center Clinical Lab, Baylor College of Medicine
|
6
|
7
|
0 |
0 |
0 |
0 |
13
|
|
Genetics and Molecular Pathology, SA Pathology
|
5
|
5
|
0 |
0 |
0 |
0 |
10
|
|
GenomeConnect, ClinGen
|
0 |
0 |
0 |
0 |
0 |
10
|
10
|
|
Clinical Genetics Laboratory, Skane University Hospital Lund
|
4
|
3
|
0 |
0 |
0 |
0 |
7
|
|
Excellence Center for Genomics and Precision Medicine, King Chulalongkorn Memorial Hospital and Chulalongkorn University, Chulalongkorn University
|
0 |
0 |
4
|
0 |
0 |
0 |
4
|
|
CHARM Consortium
|
0 |
2
|
0 |
0 |
0 |
1
|
3
|
|
Dasa
|
3
|
0 |
0 |
0 |
0 |
0 |
3
|
|
GeneID Lab - Advanced Molecular Diagnostics
|
0 |
2
|
1
|
0 |
0 |
0 |
3
|
|
Cancer Variant Interpretation Group UK, Institute of Cancer Research, London
|
1
|
1
|
0 |
0 |
0 |
0 |
2
|
|
Institute of Human Genetics, FAU Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg
|
2
|
0 |
0 |
0 |
0 |
0 |
2
|
|
Service de Génétique Médicale, Institut Central des Hôpitaux
|
0 |
0 |
2
|
0 |
0 |
0 |
2
|
|
Clinical Genetics Lab, Heritas
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
|
Department of Human Anatomy, Histology and Embryology;Department of Pathology, Peking University Health Science Center
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
|
Department of Medical and Surgical Sciences, University of Bologna
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
|
Diagnostic Molecular Genetics Laboratory, Memorial Sloan Kettering Cancer Center
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
|
GenomeConnect - Invitae Patient Insights Network
|
0 |
0 |
0 |
0 |
0 |
1
|
1
|
|
Knight Diagnostic Laboratories, Oregon Health and Sciences University
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
|
Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
The information on this website is not intended for direct
diagnostic use or medical decision-making without review by a
genetics professional. Individuals should not change their
health behavior solely on the basis of information contained on
this website. The submitted information has not been verified.
If you have questions about the information contained on this
website, please see a health care professional.